Berman Capital Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$76K Buy
1,554
+761
+96% +$41.3K 0.01% 521
2021
Q2
$45K Buy
793
+107
+16% +$6.25K 0.01% 625
2021
Q1
$41K Sell
686
-6
-0.9% -$331 0.01% 544
2020
Q4
$37K Buy
692
+329
+91% +$17.1K 0.01% 486
2020
Q3
$17K Buy
363
+18
+5% +$924 ﹤0.01% 636
2020
Q2
$18K Buy
345
+40
+13% +$2.06K ﹤0.01% 572
2020
Q1
$14K Buy
305
+160
+110% +$8.31K ﹤0.01% 579
2019
Q4
$7K Hold
145
﹤0.01% 865
2019
Q3
$6K Buy
145
+91
+169% +$4.15K ﹤0.01% 880
2019
Q2
$2K Buy
54
+4
+8% +$185 ﹤0.01% 1163
2019
Q1
$2K Sell
50
-82
-62% -$4.11K ﹤0.01% 1065
2018
Q4
$5K Buy
+132
New +$6.88K ﹤0.01% 674

Other funds holding CAH

Berman Capital Advisors's CAH Position: Q3 2021 in Review

Berman Capital Advisors increased its Cardinal Health (CAH) stake by 96% in Q3 2021, buying an estimated $41.3K and bringing the position to 1,554 shares worth $76K. The position accounts for 0.01% of the portfolio, ranked #521.

Berman Capital Advisors first reported a position in CAH in Q4 2018 and has held it in 12 quarters since. 749 funds tracked by Wall St. Rank hold CAH as of Q3 2021.

  • Berman Capital Advisors held 1,554 shares of Cardinal Health worth $76K as of Q3 2021.
  • Berman Capital Advisors bought 761 Cardinal Health shares in Q3 2021, an estimated $41.3K.
  • Cardinal Health made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #521 holding.
  • Berman Capital Advisors first reported a position in Cardinal Health in Q4 2018 and has held it in 12 quarters since.
  • 749 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.